SOTALOL

Course overview

SOTALOL HAS THE FOLLOWING ARE THE FDA AND NON-FDA INDICATIONS: PREMATURE VENTRICULAR CONTRACTIONS, HEMODYNAMICALLY STABLE VENTRICULAR TACHYCARDIA, PHARMACOLOGICAL CARDIOVERSION OF ATRIAL FIBRILLATION, MAINTAINING SINUS RHYTHM, POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY, SUPRAVENTRICULAR TACHYCARDIA, AND OTHERS. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISMS OF ACTION, METHODS OF ADMINISTRATION, SIGNIFICANT ADVERSE EFFECTS, CONTRAINDICATIONS, AND MONITORING, OF SOTALOL, SO PROVIDERS CAN DIRECT PATIENT THERAPY IN TREATING INDICATED DISORDERS AS PART OF THE INTERPROFESSIONAL TEAM, WITH A BASIS ON THE CURRENT KNOWLEDGE FOR OPTIMAL UTILIZATION.